Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ocean Genomics develops advanced AI-driven computational platforms to analyze transcriptomic data from RNA sequencing. Their technology enables biopharma companies, academic researchers, and clinical labs to discover multidimensional biomarkers from high-dimensional gene expression data. The company’s txome.ai cloud-based solution supports both research and clinical applications by integrating omics data with clinical metadata to identify novel drug targets or stratify patient populations. They have established partnerships with organizations such as Geninus to co-develop RNA-based biomarkers for diagnostics and translational medicine in oncology and beyond.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ocean Genomics.